期刊文献+

组织芯片研究MMP-9、TIMP-1在宫颈癌的表达及相关性 被引量:2

Expression of MMP-9 and TIMP-1 in Cervical Carcinoma Using Tissue Microarray and Their Correlation with Cervical Carcinoma
下载PDF
导出
摘要 目的:探讨MMP-9及TIMP-1在宫颈癌中的表达及生物学意义。方法:建立组织芯片(TissueMicroarry,TMA)技术平台,应用该技术结合免疫组织化学S-P法检测3种蛋白在宫颈癌中的表达。结果:组织芯片制备成功,脱片率为0.025%。MMP-9在正常宫颈(NCE)、宫颈上皮非典型增生(CIN)和宫颈浸润癌(1CC)的阳性率分别为21.8%、50.0%和81.7%,ICC、CIN分别与NCE比较有统计学意义(P<0.05)。TIMP-1在3组中的阳性率分别为21.9%、25.0%和27.96%,3组间无显著性差异(P>0.05)。宫颈癌中MMP-9的表达与病理分级有关(P<0.05)。伴有盆腔淋巴结转移者MMP-9阳性表达率显著增高(P<0.05),而TIMP-1表达阳性率显著降低。宫颈癌中MMP-9表达高于TIMP-1者,其盆腔淋巴结转移的发生率显著高于MMP-9与TIMP-1表达平衡者(P<0.05)。结论:建立了组织芯片,为研究宫颈癌的生物学行为提供了有力的技术平台。宫颈癌MMP-9表达增强而TIMP-1表达降低可能使宫颈癌更易发生侵袭转移。联合检测宫颈癌中MMP-9及TIMP-1的表达对进一步了解宫颈癌生物学行为和判断其预后有一定的价值。 Objective:To investigate the expression of MMP-9 and TIMP-1 in cervical carcinoma and its biological significance.Methods:The technique platoform of tissue microarray (TMA) was established.The expression of 3 proteins in cervical carcinoma was detected by TMA and immunohistochemical SP methods.Results:The preparation of TMA was successful.The rate of shedding slice was 0.025%.The positive rate of MMP-9 in normal cervical epithelium (NCE),cervical atypical hyperplasia (CIN) and invasive carcinoma of cervix (ICC) was respectively 21.8%,50.0% and 81.7%,which in ICC and CIN was statistically differed from that in NCE (P<0.05).The positive rate of TIMP-1 in NCE,CIN and ICC was 21.9%,25.0% and 27.96%,respectively.There was no difference among three groups(P>0.05).The expression of MMP-9 in cervical carcinoma was associated with pathological grades (P<0.05).In cases with pelvic lymphonade metastasis,the positive rate of MMP was increased and that of TIMP-1 was decreased.The incidence of pelvic lymphonade metastasis was higher in cervical carcinoma with higher MMP-9 than TIMP-1,compared with that with balanced expression of MMP-9 and TIMP-1(P<0.05).Conclusion:TMA provides effective technique platform for studying biological behaviour in cervical carcinoma.The cervical carcinoma with expression of MMP-9 and lower expression of TIMP-1 is apt to metastasize.The combined detection of MMP-9 with TIMP-9 is valuable in further comprehending the biological behaviour and prognosis of carvical carcinoma.
出处 《内蒙古医学杂志》 2005年第7期581-584,共4页 Inner Mongolia Medical Journal
关键词 基质金属蛋白酶类 宫颈肿瘤 转移 组织芯片 免疫组织化学 MMP Cervical tumor Metastasis Tissue microarray(TMA) Immunohistochemistry
  • 相关文献

参考文献8

  • 1刘永军,晏培松,贾敬芬.组织芯片研究CD_(44)s和CD_(44)V_6在乳腺癌组织中的表达[J].肿瘤防治杂志,2003,10(7):677-679. 被引量:3
  • 2Kugler A. Matrix metaUoproteinase and their iuhibitors[ J ] . Antieaneer Res, 1999,19 (2C) : 1589.
  • 3Okada A. Rdes of metalloproteinases and tissue iuhibitor of metalloproteinase (TIMP) in Cancer and metastasis[J] .Gan To Kagaku Ryoho, 1999,26 (14) : 2247.
  • 4ET Was , KMLM Lomme,J DeGroot, et al. Tissue levels of active matrix metalloproteinase - 2 and - 9 in colorectal cancer[ J ]. Br J Cancer, 2002,86 ( 12 ) : 1876.
  • 5Huang LW, Garrett AP, Bell DA, et al. Differential expression of matrix metalloprotelnase- 9 and tissue inhibitor of metalloproteinase- 1 protein and mRNA in epithelial ovarian tumor[ J ].Gynecol Onool,2000,77(3) :369.
  • 6李娟清,石一复,周怀君,周彩云,陈晓端.MMP-9及TIMP-1在卵巢上皮性肿瘤中的表达[J].现代妇产科进展,2003,12(3):170-172. 被引量:1
  • 7Brown PD. Matrix metalloproteinase inhibitors[J ]. Breast Cancer Res Treat, 1998,52 : 125.
  • 8Matrix metalloproteinases:structures, evolution and diversification[J ]. FASEB J, 1999,12(12) : 1075.

二级参考文献10

  • 1[1]Huang LW,Garrett AP,Bell DA,et al. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumosrs[ J]. Gynecol Oncol, 2000,77: 369-376
  • 2[2]Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function [ J ]. Biochim Biophys Acta,2000,1477:267-283
  • 3[3]Davidson B, Goldberg I, Gotlieb WH, et al. The prognostic alue of metalloproteinases and angiogenic factors in ovarian carcinoma[ J] .Mol Cell Endocrinol, 2002,187:39-45
  • 4[4]Di Nezza LA, Misajon A, Zhang J, et al. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invade[ J ]. Cancer, 2002,94:1466-1475
  • 5[5]Heslin MJ, Yan J, Johnson MR, et al. Role of matrix metallo proteinases in colorectal carcinogenesis [ J ]. Ann Surgery, 2001,233:786-792
  • 6[6]Brown PD. Matrix metalloproteinase inhibitors[ J]. Breast Can cer Res Treat, 1998,52:125-136
  • 7[7]Mannello F, Gazzanelli G. Tissue inhibitors of metallopro teinases and programmed cell death: Contndrums,contraversies and potential implications [ J ]. Apoptosis, 2001,6: 479- 482
  • 8[8]Fernandez HA, Kallenbach K, Seghezzi G, et al. Inhibition endothelial cell migration by gene transfer of tissue inhibitor metalloproteinases-1[J]. J Surg Res, 1999,82:156-162
  • 9刘剑仑.CD44基因表达与乳腺癌侵袭转移相关性的研究进展[J].广西医学,1999,21(5):920-923. 被引量:1
  • 10郭立霞,谢弘.CD44与肿瘤转移[J].生命科学,2001,13(2):60-63. 被引量:11

共引文献2

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部